Fundraising FoxMira1a Therapeutics
Baltimore, US · Founded 2020 · Florida corporation
Find your way into Mira1a Therapeutics
Sign up to see every warm intro you have to Mira1a Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mira1a Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PR
Paul Rivard, ESQNamed on SEC filing
JU
Jude UzonwanneNamed on SEC filing
CC
Chris Chapman, MDNamed on SEC filing
BK
Brad KroenigNamed on SEC filing
JM
James McNulty, CPANamed on SEC filing
HM
Hugh McColl IIINamed on SEC filing
TT
Talhia Tuck, JDNamed on SEC filing
JS
Josh SilvermanNamed on SEC filing
DV
Dave VorhoffNamed on SEC filing
AK
Adam Kaplin, MD, PhDNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$7.1M disclosed across 2 rounds · 2021–2022
▶$625KraisedAug 2022 · 8 investors · PharmaceuticalsRule 506(b)
▶$625KraisedAug 2022 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Paul Rivard, ESQExecutive Officer
- Jude UzonwanneExecutive Officer
- Chris Chapman, MDDirector
- Brad KroenigDirector
- James McNulty, CPAExecutive Officer
- Hugh McColl IIIDirector
- Talhia Tuck, JDDirector
- Josh SilvermanDirector
- Dave VorhoffDirector
- Adam Kaplin, MD, PhDExecutive Officer
- Offering amount
- $3M
- Amount sold
- $625K
- First sale
- Jul 2022
- Incorporated
- Corporation, Florida, 2020
- Federal exemptions
- 06b
▶$6.5MraisedAug 2022 · 76 investors · PharmaceuticalsRule 506(b)
▶$6.5MraisedAug 2022 · 76 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Paul Rivard, ESQExecutive Officer
- Brad KroenigDirector
- James McNulty, CPAExecutive Officer
- Adam Kaplin, MD, PhDExecutive Officer
- Josh SilvermanDirector
- Jude UzonwanneExecutive Officer
- Hugh McColl IIIDirector
- Dave VorhoffDirector
- Chris Chapman, MDDirector
- Talhia Tuck, JDDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- Sales commissions
- $292K
- Placement agents
- Skyway Capital Markets
- First sale
- Nov 2021
- Incorporated
- Corporation, Florida, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Mira1a Therapeutics raised?
- Mira1a Therapeutics has disclosed $7.1M raised across 2 rounds.
- Where is Mira1a Therapeutics headquartered?
- Mira1a Therapeutics is headquartered in Baltimore, US.